logo
Share SHARE
FONT-SIZE Plus   Neg

Integra's Flowable Wound Matrix Receives CE Mark Certification

Integra LifeSciences Holdings Corp. (IART: Quote) Friday said it has received European CE Mark Certification for its Integra Flowable Wound Matrix, a device used for filling deep soft tissue or tunneling wounds in patients suffering from diabetes.

The device has been recognized by surgeons as one of the most innovative new products available for the management of chronic wounds in diabetic patients, thereby lowering the risk of amputation.

French Society of Reconstructive and Esthetic Plastic Surgery has awarded Integra's Flowable Wound Matrix 1st place in its innovation contest.

Approximately 55 million people in the European Union suffer from diabetes, of which an estimated 3 million will develop a foot ulcer.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This footwear company outperformed in the latest first quarter, despite significant headwinds from a strong U.S. dollar, slowdown at the west coast ports and seasonably cold weather in certain key markets and less efficient operations than originally anticipated at the company's European distribution center. UK-based oil giant BP Plc. and French peer Total SA Tuesday reported lower profit for the first quarter, as oil prices declined sharply from the previous year. However, results reflected stronger overall refining environment. Hartford Financial reported a decline in first-quarter profit, despite growth in premiums, due mainly to the absence of gains recorded last year.
comments powered by Disqus
RELATED NEWS
Trade IART now with 
Follow RTT